Literature DB >> 18722851

Declining breast cancer incidence and decreased HRT use.

Merethe Kumle1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18722851     DOI： 10.1016/S0140-6736(08)61255-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

1.  A two-center study of Muslim women's views of breast cancer and breast health practices in Pakistan and the UK.

Authors:  Maggie Banning; Haroon Hafeez
Journal:  J Cancer Educ       Date:  2010-02-10       Impact factor: 2.037

2.  Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

Review 3.  Hormone replacement therapy and the risk of breast cancer.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2011-08-02       Impact factor: 66.675

4.  The potential association between postmenopausal hormone use and primary open-angle glaucoma.

Authors:  Paula Anne Newman-Casey; Nidhi Talwar; Bin Nan; David C Musch; Louis R Pasquale; Joshua D Stein
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

Review 5.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

6.  Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible.

Authors:  Emily Banks; Karen Canfell
Journal:  Breast Cancer Res       Date:  2010-02-12       Impact factor: 6.466

7.  Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.

Authors:  B Royer; W Yin; M Pegram; N Ibrahim; C Villanueva; D Mir; F Erlandsson; X Pivot
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

8.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal:  BMJ       Date:  2010-08-11

9.  Recent changes in breast cancer incidence in Spain, 1980-2004.

Authors:  Marina Pollán; Roberto Pastor-Barriuso; Eva Ardanaz; Marcial Argüelles; Carmen Martos; Jaume Galcerán; María-José Sánchez-Pérez; María-Dolores Chirlaque; Nerea Larrañaga; Ruth Martínez-Cobo; María-Cres Tobalina; Enrique Vidal; Rafael Marcos-Gragera; Antonio Mateos; Isabel Garau; María-Dolores Rojas-Martín; Rosario Jiménez; Ana Torrella-Ramos; Josefina Perucha; Maria-Eugenia Pérez-de-Rada; Susana González; María-José Rabanaque; Joan Borràs; Carmen Navarro; Esther Hernández; Angel Izquierdo; Gonzalo López-Abente; Carmen Martínez
Journal:  J Natl Cancer Inst       Date:  2009-10-26       Impact factor: 13.506

10.  Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort.

Authors:  Sarah F Marshall; Christina A Clarke; Dennis Deapen; Katherine Henderson; Joan Largent; Susan L Neuhausen; Peggy Reynolds; Giske Ursin; Pamela L Horn-Ross; Daniel O Stram; Claire Templeman; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-01-08       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.